CORD-19:954e351a7d8b5d4c275b9af0b053ce983d334547 / 156411-156647 JSONTXT

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T45","span":{"begin":0,"end":236},"obj":"Sentence"}],"text":"365 Treatment blocked the development of tachycardia, tachypnea, fever, and neutropenia completely and prevented increases in serum concentrations of TNF, IL-6, TXB 2 (a TXA 2 metabolite), and the prostacyclin metabolite 6-keto-PGF 1 α."}

{"project":"CORD-19-Sentences","denotations":[{"id":"T87207","span":{"begin":0,"end":236},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"365 Treatment blocked the development of tachycardia, tachypnea, fever, and neutropenia completely and prevented increases in serum concentrations of TNF, IL-6, TXB 2 (a TXA 2 metabolite), and the prostacyclin metabolite 6-keto-PGF 1 α."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T511","span":{"begin":76,"end":87},"obj":"Disease"}],"attributes":[{"id":"A511","pred":"mondo_id","subj":"T511","obj":"http://purl.obolibrary.org/obo/MONDO_0001475"}],"text":"365 Treatment blocked the development of tachycardia, tachypnea, fever, and neutropenia completely and prevented increases in serum concentrations of TNF, IL-6, TXB 2 (a TXA 2 metabolite), and the prostacyclin metabolite 6-keto-PGF 1 α."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T344","span":{"begin":41,"end":52},"obj":"Phenotype"},{"id":"T345","span":{"begin":54,"end":63},"obj":"Phenotype"},{"id":"T346","span":{"begin":65,"end":70},"obj":"Phenotype"},{"id":"T347","span":{"begin":76,"end":87},"obj":"Phenotype"}],"attributes":[{"id":"A344","pred":"hp_id","subj":"T344","obj":"http://purl.obolibrary.org/obo/HP_0001649"},{"id":"A345","pred":"hp_id","subj":"T345","obj":"http://purl.obolibrary.org/obo/HP_0002789"},{"id":"A346","pred":"hp_id","subj":"T346","obj":"http://purl.obolibrary.org/obo/HP_0001945"},{"id":"A347","pred":"hp_id","subj":"T347","obj":"http://purl.obolibrary.org/obo/HP_0001875"}],"text":"365 Treatment blocked the development of tachycardia, tachypnea, fever, and neutropenia completely and prevented increases in serum concentrations of TNF, IL-6, TXB 2 (a TXA 2 metabolite), and the prostacyclin metabolite 6-keto-PGF 1 α."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T583","span":{"begin":126,"end":131},"obj":"Body_part"}],"attributes":[{"id":"A583","pred":"uberon_id","subj":"T583","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"}],"text":"365 Treatment blocked the development of tachycardia, tachypnea, fever, and neutropenia completely and prevented increases in serum concentrations of TNF, IL-6, TXB 2 (a TXA 2 metabolite), and the prostacyclin metabolite 6-keto-PGF 1 α."}